In this study, we performed an expression analysis of TSPO and LAT1—the target structures of molecular imaging modalities—in patient GBM samples, as well as in orthotopic GBM mouse models, from patient-derived and murine transgenic GBM cells, modeling the different GBM genetic subtypes. This evidence concerns the gene SLC7A5 and glioblastoma.